Who is right? Or, how to judge the disagreement about HLA restriction of Nef peptides.
暂无分享,去创建一个
[1] C. Brander,et al. Identification of HIV protein‐derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine , 1995, Clinical and experimental immunology.
[2] A. Samri,et al. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef. , 1995, Journal of immunology.
[3] J. Guillet,et al. HLA‐dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding , 1995, European journal of immunology.
[4] F. Chisari,et al. Induction in vitro of a primary human antiviral cytotoxic T cell response , 1995, European journal of immunology.
[5] G Hermanson,et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. , 1995, Journal of immunology.
[6] J. Hoebeke,et al. A simple assay for detection of peptides promoting the assembly of HLA class I molecules , 1994, European journal of immunology.
[7] F. Buseyne,et al. Efficient antigen presentation to cytotoxic T lymphocytes by cells transduced with a retroviral vector expressing the HIV-1 Nef protein. , 1993, AIDS research and human retroviruses.
[8] A. Vitiello,et al. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex , 1991, The Journal of experimental medicine.
[9] B. Guy,et al. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein. , 1991, Journal of immunology.
[10] B. Moss,et al. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. , 1990, Journal of immunology.
[11] Antonio Lanzavecchia,et al. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.
[12] B. Autran,et al. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. , 1992, The Journal of clinical investigation.